RxDoctor Payments Data

Richard Hart, MD

Family Medicine · Warren, OHNPI 1225021025

Payments from drug & device makers

$2,883in general payments, 2019–2025

Across 187 payments — averaging $15.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$832
  • Amgen$585
  • Daiichi Sankyo Inc.$316
  • GSK$154
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$142
  • AbbVie$142
  • plus $713 from 16 others

What the payments were for

  • Food & beverage$2,877100%
  • Education$60%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,883 in reported general payments places this provider in the 80th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$147,420
Medicare patients
113
Services billed
2,923

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban85$68,613
OzempicSemaglutide57$62,208
JardianceEmpagliflozin31$36,313
JanuviaSitagliptin Phosphate20$26,875
FarxigaDapagliflozin Propanediol28$22,795
Trelegy ElliptaFluticasone/Umeclidin/Vilanter21$14,806
EntrestoSacubitril/Valsartan18$14,095
Repatha SyringeEvolocumab11$10,384
MovantikNaloxegol Oxalate15$6,978
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen693$5,908
MyrbetriqMirabegron12$4,838
Metoprolol Succinate188$3,211
Gabapentin334$3,083
Oxycodone Hcl465$2,869
PaxlovidNirmatrelvir/Ritonavir16$2,825

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$141$62,20857 claims
Boehringer IngelheimJardiance$33$36,31331 claims
MerckJanuvia$133$26,87520 claims
AstraZenecaFarxiga$832$22,79528 claims
GSKTrelegy Ellipta$154$14,80621 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Warren

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →